IBDEI08U ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11686,0)
 ;;=375.15^^55^624^19
 ;;^UTILITY(U,$J,358.3,11686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11686,1,3,0)
 ;;=3^Dry Eye Syndrome
 ;;^UTILITY(U,$J,358.3,11686,1,4,0)
 ;;=4^375.15
 ;;^UTILITY(U,$J,358.3,11686,2)
 ;;=Dry Eye Syndrome^37168
 ;;^UTILITY(U,$J,358.3,11687,0)
 ;;=368.40^^55^624^50
 ;;^UTILITY(U,$J,358.3,11687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11687,1,3,0)
 ;;=3^Visual Field Defect,Unspec
 ;;^UTILITY(U,$J,358.3,11687,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,11687,2)
 ;;=Visual Field Defect^126859
 ;;^UTILITY(U,$J,358.3,11688,0)
 ;;=366.53^^55^624^3
 ;;^UTILITY(U,$J,358.3,11688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11688,1,3,0)
 ;;=3^After Cataract Obscurring Vision
 ;;^UTILITY(U,$J,358.3,11688,1,4,0)
 ;;=4^366.53
 ;;^UTILITY(U,$J,358.3,11688,2)
 ;;=After Cataract Obscurring Vision^268823
 ;;^UTILITY(U,$J,358.3,11689,0)
 ;;=366.9^^55^624^10
 ;;^UTILITY(U,$J,358.3,11689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11689,1,3,0)
 ;;=3^Cataract, Unspecified
 ;;^UTILITY(U,$J,358.3,11689,1,4,0)
 ;;=4^366.9
 ;;^UTILITY(U,$J,358.3,11689,2)
 ;;=Cataract, Unspecified^20266
 ;;^UTILITY(U,$J,358.3,11690,0)
 ;;=362.83^^55^624^35
 ;;^UTILITY(U,$J,358.3,11690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11690,1,3,0)
 ;;=3^Macular Edema (CSME)
 ;;^UTILITY(U,$J,358.3,11690,1,4,0)
 ;;=4^362.83
 ;;^UTILITY(U,$J,358.3,11690,2)
 ;;=Macular Edema^89576
 ;;^UTILITY(U,$J,358.3,11691,0)
 ;;=362.52^^55^624^11
 ;;^UTILITY(U,$J,358.3,11691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11691,1,3,0)
 ;;=3^Cystoid Macular Degeneration
 ;;^UTILITY(U,$J,358.3,11691,1,4,0)
 ;;=4^362.52
 ;;^UTILITY(U,$J,358.3,11691,2)
 ;;=^268637
 ;;^UTILITY(U,$J,358.3,11692,0)
 ;;=367.22^^55^624^32
 ;;^UTILITY(U,$J,358.3,11692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11692,1,3,0)
 ;;=3^Irregular Astigmatism
 ;;^UTILITY(U,$J,358.3,11692,1,4,0)
 ;;=4^367.22
 ;;^UTILITY(U,$J,358.3,11692,2)
 ;;=^265373
 ;;^UTILITY(U,$J,358.3,11693,0)
 ;;=V45.69^^55^624^49
 ;;^UTILITY(U,$J,358.3,11693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11693,1,3,0)
 ;;=3^States Following Surg of Eye
 ;;^UTILITY(U,$J,358.3,11693,1,4,0)
 ;;=4^V45.69
 ;;^UTILITY(U,$J,358.3,11693,2)
 ;;=^317957
 ;;^UTILITY(U,$J,358.3,11694,0)
 ;;=V58.71^^55^624^4
 ;;^UTILITY(U,$J,358.3,11694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11694,1,3,0)
 ;;=3^Aftercare Following Surg of Sense Organ
 ;;^UTILITY(U,$J,358.3,11694,1,4,0)
 ;;=4
 ;;^UTILITY(U,$J,358.3,11694,2)
 ;;=^328689
 ;;^UTILITY(U,$J,358.3,11695,0)
 ;;=V45.61^^55^624^9
 ;;^UTILITY(U,$J,358.3,11695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11695,1,3,0)
 ;;=3^Cataract Extraction Status
 ;;^UTILITY(U,$J,358.3,11695,1,4,0)
 ;;=4^V45.61
 ;;^UTILITY(U,$J,358.3,11695,2)
 ;;=^295462
 ;;^UTILITY(U,$J,358.3,11696,0)
 ;;=V72.0^^55^624^21
 ;;^UTILITY(U,$J,358.3,11696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11696,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,11696,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,11696,2)
 ;;=^43432
 ;;^UTILITY(U,$J,358.3,11697,0)
 ;;=V71.89^^55^624^38
 ;;^UTILITY(U,$J,358.3,11697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11697,1,3,0)
 ;;=3^Observe SPEC Condition
 ;;^UTILITY(U,$J,358.3,11697,1,4,0)
 ;;=4^V71.89
 ;;^UTILITY(U,$J,358.3,11697,2)
 ;;=^322082
 ;;^UTILITY(U,$J,358.3,11698,0)
 ;;=V50.1^^55^624^39
 ;;^UTILITY(U,$J,358.3,11698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11698,1,3,0)
 ;;=3^Oth Plastic Surgery
 ;;^UTILITY(U,$J,358.3,11698,1,4,0)
 ;;=4^V50.1
 ;;^UTILITY(U,$J,358.3,11698,2)
 ;;=^87802
 ;;^UTILITY(U,$J,358.3,11699,0)
 ;;=368.8^^55^624^40
 ;;^UTILITY(U,$J,358.3,11699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11699,1,3,0)
 ;;=3^Oth Specific Visual Disturbances
 ;;^UTILITY(U,$J,358.3,11699,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,11699,2)
 ;;=^88172
 ;;^UTILITY(U,$J,358.3,11700,0)
 ;;=368.13^^55^624^41
 ;;^UTILITY(U,$J,358.3,11700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11700,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,11700,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,11700,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,11701,0)
 ;;=998.59^^55^624^42
 ;;^UTILITY(U,$J,358.3,11701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11701,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,11701,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,11701,2)
 ;;=^97081
 ;;^UTILITY(U,$J,358.3,11702,0)
 ;;=368.03^^55^624^5
 ;;^UTILITY(U,$J,358.3,11702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11702,1,3,0)
 ;;=3^Amblyopia,Refractive
 ;;^UTILITY(U,$J,358.3,11702,1,4,0)
 ;;=4^368.03
 ;;^UTILITY(U,$J,358.3,11702,2)
 ;;=^265363
 ;;^UTILITY(U,$J,358.3,11703,0)
 ;;=367.31^^55^624^6
 ;;^UTILITY(U,$J,358.3,11703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11703,1,3,0)
 ;;=3^Anisometropia
 ;;^UTILITY(U,$J,358.3,11703,1,4,0)
 ;;=4^367.31
 ;;^UTILITY(U,$J,358.3,11703,2)
 ;;=^7839
 ;;^UTILITY(U,$J,358.3,11704,0)
 ;;=367.20^^55^624^7
 ;;^UTILITY(U,$J,358.3,11704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11704,1,3,0)
 ;;=3^Astigmatism,NOS
 ;;^UTILITY(U,$J,358.3,11704,1,4,0)
 ;;=4^367.20
 ;;^UTILITY(U,$J,358.3,11704,2)
 ;;=^11141
 ;;^UTILITY(U,$J,358.3,11705,0)
 ;;=367.0^^55^624^31
 ;;^UTILITY(U,$J,358.3,11705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11705,1,3,0)
 ;;=3^Hypermetropia
 ;;^UTILITY(U,$J,358.3,11705,1,4,0)
 ;;=4^367.0
 ;;^UTILITY(U,$J,358.3,11705,2)
 ;;=^60139
 ;;^UTILITY(U,$J,358.3,11706,0)
 ;;=367.1^^55^624^37
 ;;^UTILITY(U,$J,358.3,11706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11706,1,3,0)
 ;;=3^Myopia
 ;;^UTILITY(U,$J,358.3,11706,1,4,0)
 ;;=4^367.1
 ;;^UTILITY(U,$J,358.3,11706,2)
 ;;=^80671
 ;;^UTILITY(U,$J,358.3,11707,0)
 ;;=V43.1^^55^624^45
 ;;^UTILITY(U,$J,358.3,11707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11707,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,11707,1,4,0)
 ;;=4^V43.1
 ;;^UTILITY(U,$J,358.3,11707,2)
 ;;=^69114
 ;;^UTILITY(U,$J,358.3,11708,0)
 ;;=367.9^^55^624^46
 ;;^UTILITY(U,$J,358.3,11708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11708,1,3,0)
 ;;=3^Refractive Error
 ;;^UTILITY(U,$J,358.3,11708,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,11708,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,11709,0)
 ;;=365.04^^55^624^26
 ;;^UTILITY(U,$J,358.3,11709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11709,1,3,0)
 ;;=3^Glaucoma Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,11709,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,11709,2)
 ;;=^85124
 ;;^UTILITY(U,$J,358.3,11710,0)
 ;;=365.01^^55^624^30
 ;;^UTILITY(U,$J,358.3,11710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11710,1,3,0)
 ;;=3^Glaucoma Suspect
 ;;^UTILITY(U,$J,358.3,11710,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,11710,2)
 ;;=^340633
 ;;^UTILITY(U,$J,358.3,11711,0)
 ;;=365.71^^55^624^24
 ;;^UTILITY(U,$J,358.3,11711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11711,1,3,0)
 ;;=3^Glaucoma Mild Stage
 ;;^UTILITY(U,$J,358.3,11711,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,11711,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,11712,0)
 ;;=365.72^^55^624^25
 ;;^UTILITY(U,$J,358.3,11712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11712,1,3,0)
 ;;=3^Glaucoma Moderate Stage
 ;;^UTILITY(U,$J,358.3,11712,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,11712,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,11713,0)
 ;;=365.73^^55^624^28
 ;;^UTILITY(U,$J,358.3,11713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11713,1,3,0)
 ;;=3^Glaucoma Severe Stage
 ;;^UTILITY(U,$J,358.3,11713,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,11713,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,11714,0)
 ;;=362.51^^55^624^1
 ;;^UTILITY(U,$J,358.3,11714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11714,1,3,0)
 ;;=3^AMD,Dry
 ;;^UTILITY(U,$J,358.3,11714,1,4,0)
 ;;=4^362.51
 ;;^UTILITY(U,$J,358.3,11714,2)
 ;;=^268636
 ;;^UTILITY(U,$J,358.3,11715,0)
 ;;=362.52^^55^624^2
 ;;^UTILITY(U,$J,358.3,11715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11715,1,3,0)
 ;;=3^AMD,Wet/Exudative
 ;;^UTILITY(U,$J,358.3,11715,1,4,0)
 ;;=4^362.52
 ;;^UTILITY(U,$J,358.3,11715,2)
 ;;=^268637
 ;;^UTILITY(U,$J,358.3,11716,0)
 ;;=362.04^^55^624^14
 ;;^UTILITY(U,$J,358.3,11716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11716,1,3,0)
 ;;=3^DM Mild NPDR
 ;;^UTILITY(U,$J,358.3,11716,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,11716,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,11717,0)
 ;;=362.05^^55^624^15
 ;;^UTILITY(U,$J,358.3,11717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11717,1,3,0)
 ;;=3^DM Moderate NPDR
 ;;^UTILITY(U,$J,358.3,11717,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,11717,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,11718,0)
 ;;=362.06^^55^624^17
 ;;^UTILITY(U,$J,358.3,11718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11718,1,3,0)
 ;;=3^DM Severe NPDR
 ;;^UTILITY(U,$J,358.3,11718,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,11718,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,11719,0)
 ;;=362.02^^55^624^16
 ;;^UTILITY(U,$J,358.3,11719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11719,1,3,0)
 ;;=3^DM PDR
 ;;^UTILITY(U,$J,358.3,11719,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,11719,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,11720,0)
 ;;=367.9^^55^624^18
 ;;^UTILITY(U,$J,358.3,11720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11720,1,3,0)
 ;;=3^Disorder of Refraction
 ;;^UTILITY(U,$J,358.3,11720,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,11720,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,11721,0)
 ;;=373.2^^55^624^36
 ;;^UTILITY(U,$J,358.3,11721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11721,1,3,0)
 ;;=3^Meibomianitis
 ;;^UTILITY(U,$J,358.3,11721,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,11721,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,11722,0)
 ;;=V58.69^^55^624^34
 ;;^UTILITY(U,$J,358.3,11722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11722,1,3,0)
 ;;=3^Long Term Use of Medication
 ;;^UTILITY(U,$J,358.3,11722,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,11722,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,11723,0)
 ;;=379.24^^55^624^51
 ;;^UTILITY(U,$J,358.3,11723,1,0)
 ;;=^358.31IA^4^2
